Olena Voinalovych
Research Subjects
Olena Voinalovych has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Dmytro Palii
National Pirogov Memorial Medical University
4 shared publications - Iryna G. Paliy
National Pirogov Memorial Medical University
4 shared publications - Oleh Ksenchyn
Vinnytsya National Pirogov Memorial Medical University, Vinnytsia, Ukraine
4 shared publications - I. V. Chernova
National Pirogov Memorial Medical University
2 shared publications - Olena Haiduk
National Pirogov Memorial Medical University
2 shared publications - Philip Morisky
Adherence, California, USA
2 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Professional Event, LLC in Family medicine. European practices
- No. 3,p. 82-91
Pilot study of the effects of a postbiotic based on Lactobacillus delbrueckii subsp. bulgaricus lysate on endotoxemia, cognitive functions, and fatigue in patients with MASLD
The objective: to evaluate the effect of a postbiotic based on Lactobacillus (L.) delbrueckii subsp. bulgaricus lysate on indicators of endotoxemia, cognitive functions, subjective fatigue, and quality of life in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Materials and methods. An open-label, pilot, single-center, prospective study with pre- and post-intervention assessment was conducted. The final analysis included 31 patients with a verified diagnosis of MASLD. All participants received a 30-day course of a postbiotic based on L. delbrueckii subsp. bulgaricus lysate. Changes in blood serum lipopolysaccharide-binding protein (LBP) concentration and fatigue severity assessed via the Fatigue Impact Scale (FIS) served as primary endpoints. Secondary endpoints included the dynamics of cognitive functions evaluated using the Animal Naming Test (ANT), and quality of life measures assessed with the EuroQol 5-Dimension 5-Level Questionnaire and the Visual Analog Scale (VAS).Results. Following the 30-day of postbiotic use a significant decrease in mean blood serum LBP level was observed (p < 0.001) with a large effect size (d = 1.63), which may indicate a reduction in endotoxemia. Cognitive functions significantly improved based on the rapid ANT results (p < 0.001; d = 0.95). Concurrently, a statistically significant reduction in the total FIS score was found (p = 0.0015; d = 0.63), accompanied by a parallel improvement in the subjective self-assessment of general health status according to the VAS (p = 0.003; d = 0.59). Structural Equation Modeling demonstrated that the association between reductions in LBP level and decreased fatigue in patients with MASLD may be partially mediated by improvements in cognitive function, whereas the direct effect remained statistically non-significant.Conclusions. In patients with MASLD, administration of a postbiotic based on a lysate of L. delbrueckii subsp. bulgaricus was associated with reductions in LBP level, improvement in cognitive function, and decreased subjective fatigue. Given the open-label uncontrolled study design, small sample size, and short follow-up period, these findings should be considered preliminary. The results obtained support further investigation into targeted modulation of the “gut-liver” axis in randomised controlled trials.
- 29 September 2026
- Published by Professional Event, LLC in Family medicine. European practices
- No. 3,p. 82-91
Open AccessPilot study of the effects of a postbiotic based on Lactobacillus delbrueckii subsp. bulgaricus lysate on endotoxemia, cognitive functions, and fatigue in patients with MASLD
The objective: to evaluate the effect of a postbiotic based on Lactobacillus (L.) delbrueckii subsp. bulgaricus lysate on indicators of endotoxemia, cognitive functions, subjective fatigue, and quality of life in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Materials and methods. An open-label, pilot, single-center, prospective study with pre- and post-intervention assessment was conducted. The final analysis included 31 patients with a verified diagnosis of MASLD. All participants received a 30-day course of a postbiotic based on L. delbrueckii subsp. bulgaricus lysate. Changes in blood serum lipopolysaccharide-binding protein (LBP) concentration and fatigue severity assessed via the Fatigue Impact Scale (FIS) served as primary endpoints. Secondary endpoints included the dynamics of cognitive functions evaluated using the Animal Naming Test (ANT), and quality of life measures assessed with the EuroQol 5-Dimension 5-Level Questionnaire and the Visual Analog Scale (VAS).Results. Following the 30-day of postbiotic use a significant decrease in mean blood serum LBP level was observed (p < 0.001) with a large effect size (d = 1.63), which may indicate a reduction in endotoxemia. Cognitive functions significantly improved based on the rapid ANT results (p < 0.001; d = 0.95). Concurrently, a statistically significant reduction in the total FIS score was found (p = 0.0015; d = 0.63), accompanied by a parallel improvement in the subjective self-assessment of general health status according to the VAS (p = 0.003; d = 0.59). Structural Equation Modeling demonstrated that the association between reductions in LBP level and decreased fatigue in patients with MASLD may be partially mediated by improvements in cognitive function, whereas the direct effect remained statistically non-significant.Conclusions. In patients with MASLD, administration of a postbiotic based on a lysate of L. delbrueckii subsp. bulgaricus was associated with reductions in LBP level, improvement in cognitive function, and decreased subjective fatigue. Given the open-label uncontrolled study design, small sample size, and short follow-up period, these findings should be considered preliminary. The results obtained support further investigation into targeted modulation of the “gut-liver” axis in randomised controlled trials.
- Open Access
- 26 December 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 4,p. 60-68
Adherence to Treatment in Different Cohorts: Assessment Using the MMAS-8 Questionnaire (Ukrainian version) and Determinants of Compliance in Individuals with HIV Infection and Viral Hepatitis
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome remain one of the leading global health threats. The basis of treatment is a combination antiretroviral therapy, which suppresses viral replication but does not provide complete elimination, therefore, it requires lifelong treatment. Assessment of adherence to treatment in such patients is an important component of the effectiveness of therapy, for which we used the Morisky-8 questionnaire (MMAS-8 – Morisky Medication Adherence Scale-8) that we had previously translated. The objective: to conduct pilot testing of the translated Ukrainian version of the MMAS-8 treatment adherence scale in people with HIV and comparative analysis of the impact of individual factors on treatment adherence in people with HIV and patients infected with hepatitis B (HBV) or C (HCV) virus. Materials and methods. The study involved 62 people with HIV who were receiving outpatient treatment at the MNPE “Clinical Center for Infectious Diseases” of the Vinnytsya Regional Council. All participants completed the MMAS-8 questionnaire independently. In addition to determining the level of treatment adherence, we analysed the impact on adherence to treatment of individual socio-demographic factors, adherence to a healthy lifestyle, the presence of harmful habits, the presence of side effects of medications, and the number of medications/number of tablets taken by the patient per day. Results. In the group of people with HIV, the level of treatment adherence had a negative correlation with smoking (p < 0.001), frequency of alcohol consumption (p < 0.001) and the presence of side effects of medications in the anamnesis (p < 0.001), and a positive correlation with the attitude to a healthy lifestyle (p = 0.05), sports (p = 0.03) and satisfaction with medical care (p = 0.003). During a similar analysis in the group of patients with HBV or HCV infection, a negative correlation of the level of treatment adherence with smoking (p = 0.03) and frequency of alcohol consumption (p = 0.03) was established, and a positive correlation with the attitude to a healthy lifestyle (p = 0.02) and the nature of work (p = 0.004) was found. Conclusions. We found that among the surveyed people with HIV, 51.6% were patients with a high degree of adherence, 22.6% with a medium degree, and 25.8% with a low degree of treatment adherence. Pilot testing of the Ukrainian version of the eight-item MMAS-8 showed sufficient reliability and validity of the specified tool for assessing adherence to treatment in people with HIV, both in clinical practice and in scientific research.
- 26 December 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 4,p. 60-68
Open AccessAdherence to Treatment in Different Cohorts: Assessment Using the MMAS-8 Questionnaire (Ukrainian version) and Determinants of Compliance in Individuals with HIV Infection and Viral Hepatitis
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome remain one of the leading global health threats. The basis of treatment is a combination antiretroviral therapy, which suppresses viral replication but does not provide complete elimination, therefore, it requires lifelong treatment. Assessment of adherence to treatment in such patients is an important component of the effectiveness of therapy, for which we used the Morisky-8 questionnaire (MMAS-8 – Morisky Medication Adherence Scale-8) that we had previously translated. The objective: to conduct pilot testing of the translated Ukrainian version of the MMAS-8 treatment adherence scale in people with HIV and comparative analysis of the impact of individual factors on treatment adherence in people with HIV and patients infected with hepatitis B (HBV) or C (HCV) virus. Materials and methods. The study involved 62 people with HIV who were receiving outpatient treatment at the MNPE “Clinical Center for Infectious Diseases” of the Vinnytsya Regional Council. All participants completed the MMAS-8 questionnaire independently. In addition to determining the level of treatment adherence, we analysed the impact on adherence to treatment of individual socio-demographic factors, adherence to a healthy lifestyle, the presence of harmful habits, the presence of side effects of medications, and the number of medications/number of tablets taken by the patient per day. Results. In the group of people with HIV, the level of treatment adherence had a negative correlation with smoking (p < 0.001), frequency of alcohol consumption (p < 0.001) and the presence of side effects of medications in the anamnesis (p < 0.001), and a positive correlation with the attitude to a healthy lifestyle (p = 0.05), sports (p = 0.03) and satisfaction with medical care (p = 0.003). During a similar analysis in the group of patients with HBV or HCV infection, a negative correlation of the level of treatment adherence with smoking (p = 0.03) and frequency of alcohol consumption (p = 0.03) was established, and a positive correlation with the attitude to a healthy lifestyle (p = 0.02) and the nature of work (p = 0.004) was found. Conclusions. We found that among the surveyed people with HIV, 51.6% were patients with a high degree of adherence, 22.6% with a medium degree, and 25.8% with a low degree of treatment adherence. Pilot testing of the Ukrainian version of the eight-item MMAS-8 showed sufficient reliability and validity of the specified tool for assessing adherence to treatment in people with HIV, both in clinical practice and in scientific research.
- Open Access
- 24 September 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 3,p. 144-149
Adaptation and Validation of the Ukrainian Version of the Morisky Medication Adherence Scale-8 (MMAS-8) in Patients with HBV and HCV Infection
Despite the effective current approaches to the treatment of HBV and HCV infections, maintaining long-term adherence to antiviral drugs in patients is a challenge. The need to assess adherence to treatment requires a simple and effective tool for this, which is the Morisky Medication Adherence Scale-8 (MMAS-8) questionnaire, recognized by the researchers from different countries. However, until now, there was no Ukrainian-language version of this questionnaire. The objective: to translate, carry out a cross-cultural adaptation and validation of the Ukrainian version of the MMAS-8 treatment adherence scale. Materials and methods. According to the recommendations of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), we translated and cross-culturally adapted the original English version of the MMAS-8 questionnaire. 60 patients with HBV or HCV infection took part in the pilot testing of the Ukrainian-language version of the MMAS-8 questionnaire, including 46 men and 14 women. The comprehensibility and complexity of the Ukrainian version of the MMAS-8 was assessed using a Likert scale. To calculate the reliability of the Ukrainian-language version of the MMAS-8 questionnaire, a repeated survey (test-retest method) was conducted with an interval of 7 days. Internal consistency of questions was determined using Cronbach’s α coefficient. Results. It was established that among the surveyed patients, 80% had a high degree of adherence to treatment, 18.3% – an average degree, and 1.7% – a low degree of adherence to treatment. The comprehensibility index and the difficulty index of the translated version of the MMAS-8 were 1.0/1.0, respectively. The reliability of the Ukrainian-language version of the MMAS-8 was established with a reliable correlation coefficient between test-retest results (r = 0.89). The internal consistency of the Ukrainian version of the MMAS-8 questionnaire (by Cronbach’s α reliability method) was 0.74 at an acceptable level of > 0.7. Conclusions. During the translation, adaptation and validation of the Ukrainian version of the MMAS-8, the recommendations of the ISPOR guidelines were taken into account, following which it is possible to avoid bias and ensure the maximum semantic and cultural relevance of the questionnaire. The results of the study demonstrate that the Ukrainian-language version of the Morisky Medication Adherence Scale-8 (MMAS-8) is understandable and uncomplicated for patients, a reliable and valid tool for assessing adherence to treatment in patients with HBV and HCV infection both in clinical practice and in scientific research.
- 24 September 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 3,p. 144-149
Open AccessAdaptation and Validation of the Ukrainian Version of the Morisky Medication Adherence Scale-8 (MMAS-8) in Patients with HBV and HCV Infection
Despite the effective current approaches to the treatment of HBV and HCV infections, maintaining long-term adherence to antiviral drugs in patients is a challenge. The need to assess adherence to treatment requires a simple and effective tool for this, which is the Morisky Medication Adherence Scale-8 (MMAS-8) questionnaire, recognized by the researchers from different countries. However, until now, there was no Ukrainian-language version of this questionnaire. The objective: to translate, carry out a cross-cultural adaptation and validation of the Ukrainian version of the MMAS-8 treatment adherence scale. Materials and methods. According to the recommendations of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), we translated and cross-culturally adapted the original English version of the MMAS-8 questionnaire. 60 patients with HBV or HCV infection took part in the pilot testing of the Ukrainian-language version of the MMAS-8 questionnaire, including 46 men and 14 women. The comprehensibility and complexity of the Ukrainian version of the MMAS-8 was assessed using a Likert scale. To calculate the reliability of the Ukrainian-language version of the MMAS-8 questionnaire, a repeated survey (test-retest method) was conducted with an interval of 7 days. Internal consistency of questions was determined using Cronbach’s α coefficient. Results. It was established that among the surveyed patients, 80% had a high degree of adherence to treatment, 18.3% – an average degree, and 1.7% – a low degree of adherence to treatment. The comprehensibility index and the difficulty index of the translated version of the MMAS-8 were 1.0/1.0, respectively. The reliability of the Ukrainian-language version of the MMAS-8 was established with a reliable correlation coefficient between test-retest results (r = 0.89). The internal consistency of the Ukrainian version of the MMAS-8 questionnaire (by Cronbach’s α reliability method) was 0.74 at an acceptable level of > 0.7. Conclusions. During the translation, adaptation and validation of the Ukrainian version of the MMAS-8, the recommendations of the ISPOR guidelines were taken into account, following which it is possible to avoid bias and ensure the maximum semantic and cultural relevance of the questionnaire. The results of the study demonstrate that the Ukrainian-language version of the Morisky Medication Adherence Scale-8 (MMAS-8) is understandable and uncomplicated for patients, a reliable and valid tool for assessing adherence to treatment in patients with HBV and HCV infection both in clinical practice and in scientific research.
- Open Access
- 29 February 2024
- Published by Professional Event, LLC in Family medicine. European practices
- No. 1,p. 52-56
Rabies Clinical Perspective: Case Description and Care Strategies
The information in the article is useful for a wide range of medical professionals, including infectious disease physicians, epidemiologists, traumatologists, family doctors, as well as medical university students. Rabies is a highly contagious and incurable viral disease that affects the central nervous system that leads to severe encephalitis. This disease is common in 150 countries and territories of the world on all continents except Antarctica. Although the virus can be present in a variety of mammals, the main reservoirs in the wild nature are two specific genera. The most global threat is rabid dogs. The article analyzes the current situation regarding rabies in Ukraine, with a special emphasis on the Vinnytsia region. By collecting information on the prevalence of rabies cases and analyzing medical records of hospitalized patients, we aim to raise awareness of the severity of the disease and highlight prevention measures. The clinical case presented in this study is a tool to draw attention to the problem of the spread of rabies. By telling about this case, we hope to inform the society about the frightening consequences of the disease and promote preventive measures. Solving this issue requires a multifaceted approach. For the effective combat of the rabies spread, it is necessary to review the current restrictions and bans on hunting in the entire territory of Ukraine, in particular in the Vinnytsia region. In addition, more attention should be paid to informing the population through mass media and strengthening the preventive work of medical workers. It is advisable to strengthen control over the vaccination of domestic animals, as this can significantly contribute to the prevention of transmission of the virus. At the same time, it is extremely important to ensure that sufficient quantities of rabies vaccine and immunoglobulin are available for effective treatment and prevention of further cases.
- 29 February 2024
- Published by Professional Event, LLC in Family medicine. European practices
- No. 1,p. 52-56
Open AccessRabies Clinical Perspective: Case Description and Care Strategies
The information in the article is useful for a wide range of medical professionals, including infectious disease physicians, epidemiologists, traumatologists, family doctors, as well as medical university students. Rabies is a highly contagious and incurable viral disease that affects the central nervous system that leads to severe encephalitis. This disease is common in 150 countries and territories of the world on all continents except Antarctica. Although the virus can be present in a variety of mammals, the main reservoirs in the wild nature are two specific genera. The most global threat is rabid dogs. The article analyzes the current situation regarding rabies in Ukraine, with a special emphasis on the Vinnytsia region. By collecting information on the prevalence of rabies cases and analyzing medical records of hospitalized patients, we aim to raise awareness of the severity of the disease and highlight prevention measures. The clinical case presented in this study is a tool to draw attention to the problem of the spread of rabies. By telling about this case, we hope to inform the society about the frightening consequences of the disease and promote preventive measures. Solving this issue requires a multifaceted approach. For the effective combat of the rabies spread, it is necessary to review the current restrictions and bans on hunting in the entire territory of Ukraine, in particular in the Vinnytsia region. In addition, more attention should be paid to informing the population through mass media and strengthening the preventive work of medical workers. It is advisable to strengthen control over the vaccination of domestic animals, as this can significantly contribute to the prevention of transmission of the virus. At the same time, it is extremely important to ensure that sufficient quantities of rabies vaccine and immunoglobulin are available for effective treatment and prevention of further cases.
- Open Access
- 1 November 2021
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 23 (6) , 882-888
Congenital hepatic fibrosis (a case report)
The aim of this work is to familiarize specialists with the problem of diagnosis and treatment of type I CHF in a patient with a provisional misdiagnosis of cryptogenic liver cirrhosis. Results. The features of type I CHF that determine a wider diagnostic testing in long-term unspecified liver pathology cases were identified. First-time decompensation of portal hypertension (PH) occurred at 35 weeks of gestation with the development of ascitic-edematous syndrome, hypersplenism, preeclampsia without signs of hepatic encephalopathy (HE). Cesarean section was performed at 37 weeks' gestation and healthy baby was born. One year and 9 months after delivery, hypersplenism compensation was achieved by performing splenic artery embolization (SAE). There were no clinical manifestations of HE throughout the follow-up period. Conclusions. The diagnostic algorithm for a long-term compensated unspecified liver pathology with PH should confirm or rule out CHF. Type I CHF patients can give birth to a healthy child. SAE successfully compensates for hypersplenism and PH in type I CHF. Transient elastography is an effective method for the assessment of liver fibrosis progression in patients with type I CHF.
- 1 November 2021
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 23 (6) , 882-888
Open AccessCongenital hepatic fibrosis (a case report)
The aim of this work is to familiarize specialists with the problem of diagnosis and treatment of type I CHF in a patient with a provisional misdiagnosis of cryptogenic liver cirrhosis. Results. The features of type I CHF that determine a wider diagnostic testing in long-term unspecified liver pathology cases were identified. First-time decompensation of portal hypertension (PH) occurred at 35 weeks of gestation with the development of ascitic-edematous syndrome, hypersplenism, preeclampsia without signs of hepatic encephalopathy (HE). Cesarean section was performed at 37 weeks' gestation and healthy baby was born. One year and 9 months after delivery, hypersplenism compensation was achieved by performing splenic artery embolization (SAE). There were no clinical manifestations of HE throughout the follow-up period. Conclusions. The diagnostic algorithm for a long-term compensated unspecified liver pathology with PH should confirm or rule out CHF. Type I CHF patients can give birth to a healthy child. SAE successfully compensates for hypersplenism and PH in type I CHF. Transient elastography is an effective method for the assessment of liver fibrosis progression in patients with type I CHF.